2018
DOI: 10.1016/j.ajo.2018.07.014
|View full text |Cite
|
Sign up to set email alerts
|

Reporting Harm in Glaucoma Surgical Trials: Systematic Review and a Consensus-Derived New Classification System

Abstract: Glaucoma surgical randomized controlled trials report frequency of complications, but their severity is rarely reported. The quality of harm reporting is poor. We propose the use of a newly developed system of classification for assessing the severity of surgical complications based on consensus.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
9

Relationship

5
4

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 73 publications
(51 reference statements)
0
17
0
1
Order By: Relevance
“…24 25 In our study, the marked reduction of IOP and number of medications was statistically significant at all postoperative time points. There were no major complications 26 in any patient, and the combination of cataract surgery and GATT maintained the same effectiveness as GATT alone in pseudophakic patients. In 6 out of 103 eyes, a complete 360-degree trabeculotomy was not achieved; however, all these partial cases were successful.…”
Section: Discussionmentioning
confidence: 67%
“…24 25 In our study, the marked reduction of IOP and number of medications was statistically significant at all postoperative time points. There were no major complications 26 in any patient, and the combination of cataract surgery and GATT maintained the same effectiveness as GATT alone in pseudophakic patients. In 6 out of 103 eyes, a complete 360-degree trabeculotomy was not achieved; however, all these partial cases were successful.…”
Section: Discussionmentioning
confidence: 67%
“…The reason that certain complications are deemed acceptable for some MIGS devices, but not others lies in the context in which they are used. In this regard, in a recent systematic review and consensus derived classification system of reporting harm in glaucoma surgical trials, endothelial cell loss, in the absence of corneal oedema, was noteven a significant consideration for the participating glaucoma surgeons 7. As the first ab-interno glaucoma surgical device which drains to the suprachoroidal space, the Cypass Micro-Stent gained FDA approval through Premarket Approval (PMA), which is the most stringent regulatory category for medical devices.…”
mentioning
confidence: 99%
“…Possible n = number. * The complications were graded on a scale from 1 to 10; 1 being clinically insignificant and 10 being most severe (Sii et al 2018). ** Symptomatic cataract decreasing vision at least two lines.…”
Section: Discussionmentioning
confidence: 99%
“…Complications were graded according to severity from 1 to 10 (1 being clinically insignificant and 10 being most severe) based on a recently published classification system of glaucoma surgical complications (Sii et al 2018).…”
Section: Patient Follow-up and Acquisition Of Clinical Datamentioning
confidence: 99%